Geode Capital Management LLC Purchases 7,721 Shares of Core Laboratories Inc. (NYSE:CLB)

Geode Capital Management LLC lifted its position in shares of Core Laboratories Inc. (NYSE:CLB) by 0.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,053,204 shares of the oil and gas company’s stock after purchasing an additional 7,721 shares during the quarter. Geode Capital Management LLC owned 2.24% of Core Laboratories worth $19,521,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Disciplined Growth Investors Inc. MN raised its stake in Core Laboratories by 26.7% during the 3rd quarter. Disciplined Growth Investors Inc. MN now owns 5,653,591 shares of the oil and gas company’s stock worth $104,761,000 after buying an additional 1,192,871 shares during the period. Earnest Partners LLC increased its holdings in shares of Core Laboratories by 6.3% in the second quarter. Earnest Partners LLC now owns 3,286,438 shares of the oil and gas company’s stock worth $66,682,000 after acquiring an additional 195,756 shares in the last quarter. State Street Corp raised its position in shares of Core Laboratories by 2.9% during the third quarter. State Street Corp now owns 1,975,016 shares of the oil and gas company’s stock worth $36,597,000 after purchasing an additional 56,187 shares during the period. Royce & Associates LP lifted its holdings in shares of Core Laboratories by 9.0% during the 3rd quarter. Royce & Associates LP now owns 1,021,121 shares of the oil and gas company’s stock valued at $18,921,000 after purchasing an additional 84,022 shares in the last quarter. Finally, Fisher Asset Management LLC grew its position in shares of Core Laboratories by 19.5% in the 3rd quarter. Fisher Asset Management LLC now owns 990,267 shares of the oil and gas company’s stock valued at $18,350,000 after purchasing an additional 161,278 shares during the period. Institutional investors and hedge funds own 97.81% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have weighed in on the stock. Citigroup cut their price target on shares of Core Laboratories from $15.00 to $14.00 and set a “sell” rating on the stock in a research note on Thursday, October 31st. StockNews.com raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Two investment analysts have rated the stock with a sell rating and three have given a hold rating to the company. Based on data from MarketBeat.com, Core Laboratories presently has a consensus rating of “Hold” and a consensus target price of $17.00.

Core Laboratories Trading Down 1.9 %

NYSE:CLB opened at $16.74 on Friday. The company has a market cap of $785.94 million, a P/E ratio of 25.75, a price-to-earnings-growth ratio of 1.36 and a beta of 2.35. Core Laboratories Inc. has a twelve month low of $13.82 and a twelve month high of $25.13. The business has a 50 day moving average price of $19.41 and a two-hundred day moving average price of $19.63. The company has a quick ratio of 1.79, a current ratio of 2.48 and a debt-to-equity ratio of 0.55.

Core Laboratories (NYSE:CLB) last announced its earnings results on Wednesday, October 23rd. The oil and gas company reported $0.25 EPS for the quarter, topping the consensus estimate of $0.21 by $0.04. Core Laboratories had a net margin of 5.83% and a return on equity of 15.84%. The business had revenue of $134.40 million during the quarter, compared to analysts’ expectations of $134.16 million. During the same quarter in the prior year, the company posted $0.22 earnings per share. The firm’s revenue was up 7.2% on a year-over-year basis. As a group, analysts expect that Core Laboratories Inc. will post 0.8 EPS for the current fiscal year.

Core Laboratories Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, November 25th. Investors of record on Monday, November 4th were given a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.24%. The ex-dividend date was Monday, November 4th. Core Laboratories’s dividend payout ratio is currently 6.15%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.